da Silva Antunes Ricardo, Fajardo-Rosas Vicente, Yu Esther Dawen, Gálvez Rosa Isela, Abawi Adam, Alexandar Escarrega E, Martínez-Pérez Amparo, Johansson Emil, Goodwin Benjamin, Frazier April, Dan Jennifer M, Crotty Shane, Seumois Grégory, Weiskopf Daniela, Vijayanand Pandurangan, Sette Alessandro
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA 92037, USA.
These authors contributed equally.
bioRxiv. 2025 Jan 9:2025.01.08.631842. doi: 10.1101/2025.01.08.631842.
The long-term effects of repeated COVID-19 vaccinations on adaptive immunity remain incompletely understood. Here, we conducted a comprehensive three-year longitudinal study examining T cell and antibody responses in 78 vaccinated individuals without reported symptomatic infections. We observed distinct dynamics in Spike-specific humoral and cellular immune responses across multiple vaccine doses. While antibody titers incrementally increased and stabilized with each booster, T cell responses rapidly plateaued, maintaining remarkable stability across CD4+ and CD8+ subsets. Notably, approximately 30% of participants showed CD4+ T cell reactivity to non-Spike antigens, consistent with asymptomatic infections. Single-cell RNA sequencing revealed a diverse landscape of Spike-specific T cell phenotypes, with no evidence of increased exhaustion or significant functional impairment. However, qualitative changes were observed in individuals with evidence of asymptomatic infection, exhibiting unique immunological characteristics, including increased frequencies of Th17-like CD4+ T cells and GZMKhi/IFNR CD8+ T cell subsets. Remarkably, repeated vaccinations in this group were associated with a progressive increase in regulatory T cells, potentially indicating a balanced immune response that may mitigate immunopathology. By regularly stimulating T cell memory, boosters contribute to a stable and enhanced immune response, which may provide better protection against symptomatic infections.
重复接种新冠疫苗对适应性免疫的长期影响仍未完全了解。在此,我们进行了一项为期三年的全面纵向研究,检测了78名未报告有症状感染的接种疫苗个体的T细胞和抗体反应。我们观察到多次接种疫苗后,针对刺突蛋白的体液免疫和细胞免疫反应呈现出不同的动态变化。虽然每次加强接种后抗体滴度逐渐升高并趋于稳定,但T细胞反应迅速达到平台期,在CD4+和CD8+亚群中保持显著稳定。值得注意的是,约30%的参与者表现出CD4+ T细胞对非刺突抗原的反应性,这与无症状感染一致。单细胞RNA测序揭示了刺突蛋白特异性T细胞表型的多样性,没有证据表明耗竭增加或功能显著受损。然而,在有无症状感染证据的个体中观察到了定性变化,表现出独特的免疫特征,包括Th17样CD4+ T细胞和GZMKhi/IFNR CD8+ T细胞亚群频率增加。值得注意的是,该组中重复接种疫苗与调节性T细胞的逐渐增加有关,这可能表明一种平衡的免疫反应,可能减轻免疫病理。通过定期刺激T细胞记忆,加强接种有助于产生稳定且增强的免疫反应,这可能为预防有症状感染提供更好的保护。